Johnson Financial Group, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1477024
RACINE, WI
Position in REGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,640,883
+$157,778 QoQ
Shares Held
3,418
+6.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.1808074897601.ToString("F0")%
Shared 0.ToString("F0")%
None 0.8191925102399065.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Johnson Financial Group, Inc. holds $3,060,900 across 22 Biotechnology names. REGN ranks #1 (86.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,418 | $2,640,883 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,858 | $165,469 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
338 | $150,930 | |
| 4 | KLRS |
Kalaris Therapeutics, Inc.
|
10,000 | $57,700 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
687 | $22,822 | |
| 6 | INCY |
Incyte Corp
|
46 | $4,329 | |
| 7 | ENTA |
Enanta Pharmaceuticals Inc
|
188 | $2,374 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7 | $2,316 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,640,883 | 3,418 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $2,483,105 | 3,217 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,768,900 | 3,146 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,720,950 | 3,278 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,871,612 | 2,951 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,889,810 | 2,653 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,957,137 | 2,813 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,897,689 | 2,757 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $878,753 | 913 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $761,476 | 867 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $924,183 | 1,123 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $954,938 | 1,329 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,230,860 | 1,498 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $843,420 | 1,169 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $791,510 | 1,149 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $802,753 | 1,358 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $923,310 | 1,322 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $800,767 | 1,268 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $698,982 | 1,155 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $695,939 | 1,246 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $528,023 | 1,116 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $562,339 | 1,164 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $671,735 | 1,200 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $611,799 | 981 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $529,794 | 1,085 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||